Waugh Jacob
Insider CIK 1597580 · RVNC Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2015-05-19 | 2015-05-21 | 3,131 | $25.94 | $81.2K | 28,413 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-01-28 | 2015-01-30 | 37,081 | — | $0 | 37,081 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2015-01-28 | 2015-01-30 | 6,544 | — | $0 | 31,544 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2014-09-17 | 2014-09-19 | 8,611 | — | $0 | 43,055 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2014-09-17 | 2014-09-19 | 48,437 | — | $0 | 106,563 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2014-09-17 | 2014-09-19 | 1,666 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2014-09-17 | 2014-09-19 | 5,000 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2014-09-17 | 2014-09-19 | 5,666 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-09-17 | 2014-09-19 | 11,632 | $20.62 | $239.9K | 54,033 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-09-17 | 2014-09-19 | 700 | $21.26 | $14.9K | 53,333 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-09-17 | 2014-09-19 | 25,833 | $20.58 | $531.6K | 27,500 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-09-17 | 2014-09-19 | 2,500 | $21.27 | $53.2K | 25,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2014-09-17 | 2014-09-19 | 5,000 | $2.55 | $12.8K | 59,999 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2014-09-17 | 2014-09-19 | 5,666 | $2.55 | $14.4K | 65,665 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2014-09-17 | 2014-09-19 | 48,437 | $8.70 | $421.4K | 114,102 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2014-09-17 | 2014-09-19 | 8,611 | $9.15 | $78.8K | 122,713 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-09-17 | 2014-09-19 | 8,611 | $21.50 | $185.1K | 114,102 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-09-17 | 2014-09-19 | 44,137 | $20.60 | $909.2K | 69,965 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-09-17 | 2014-09-19 | 4,300 | $21.28 | $91.5K | 65,665 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2014-09-17 | 2014-09-19 | 1,666 | $6.60 | $11.0K | 54,999 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2014-08-18 | 2014-08-20 | 25,000 | $24.47 | $611.8K | 53,333 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2014-05-19 | 2014-05-21 | 55,000 | — | $0 | 55,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2014-05-19 | 2014-05-21 | 25,000 | $32.22 | $805.5K | 78,333 | SEC↗ |